Biochip Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Biochip Market to 2027 - Global Analysis and Forecasts By Type (DNA Chips, Protein Chips, Lab-On-A-Chip and Other Arrays), End User (Hospitals & Diagnostics Centers, Academic & Research Institutes and Biotechnology & Pharmaceutical Companies) and Geography

Report Code: TIPBT00002600 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
A biochip is a collection of microarrays (micro-test sites), that is arranged on a solid substrate. A biochip is also known as genetic chip that allows the multiple diagnostic or clinical tests at the same time to be performed. This chip can performs a thousands in number of biochemical reactions in few seconds. The biochips are used for various purposes such as DNA analysis, oxygen detection, pH detection and genetic decoders among others.

The biochip market is anticipated to grow with a significant rate in the coming years, owing to factors such as, increasing development of targeted and personalized medicines for cancer treatment, growing applications in the field of proteomics, genomics, gene sequencing, drug discovery and many more. However, the increasing applications for biochips is anticipated to offer growth opportunities for the players operating in the biochip market.

The "Global Biochip Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a focus on the global market trend. The report aims to provide an overview of global biochip market with detailed market segmentation by type, end-user, and geography. The global biochip market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

The global biochip market is segmented on the basis of type, fabrication technology, application, and end-user. The biochip market is segmented into DNA chips, protein chips, Lab-On-A-Chip and other array. The other arrays segment is further bifurcated into tissue arrays and cell arrays. Based on the end user, the biochip market is segmented into hospitals & diagnostics centers, academic & research institutes, biotechnology & pharmaceutical companies.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global biochip market based on type and end-user. It also provides market size and forecast till 2027 for overall biochip market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

North America accounted for the largest market share of biochip market, owing to the factors such as, increasing R&D activities and rising prevalence of cancer in the region. However, Asia-Pacific region is expected fastest growth during the forecast period owing to rising geriatric population in the region.
The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

The report also includes the profiles of key biochip manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Thermo Fisher Scientific Inc, Bio-Rad Laboratories, Inc., Abbott, Illumina, Inc., GENERAL ELECTRIC, Agilent Technologies, Inc., PerkinElmer Inc., F. Hoffmann-La Roche Ltd, Fluidigm Corporation and Cepheid among others.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

2. KEY TAKEAWAYS

3. BIOCHIP MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Biochip Market - By Type
3.2.2. Biochip Market - By End User
3.2.3. Biochip Market - By Region
3.2.3.1. By Country
3.3. PEST ANALYSIS
3.3.1. North America - PEST Analysis
3.3.2. Europe - PEST Analysis
3.3.3. Asia Pacific - PEST Analysis
3.3.4. Middle East and Africa - PEST Analysis
3.3.5. South and Central America- PEST Analysis

4. BIOCHIP MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS

5. BIOCHIP MARKET - GLOBAL ANALYSIS
5.1. GLOBAL BIOCHIP MARKET OVERVIEW
5.2. GLOBAL BIOCHIP MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. PERFORMANCE OF KEY PLAYERS
5.4. CLINICAL TRIALS
5.5. EXPERT OPINIONS

6. BIOCHIP MARKET REVENUE AND FORECASTS TO 2027 - BY TYPE
6.1. OVERVIEW
6.2. TYPE MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
6.3. DNA CHIPS MARKET
6.3.1. Overview
6.3.2. DNA Chips Market Revenue Forecasts and Analysis (US$ Mn)
6.4. PROTEIN CHIPS MARKET
6.4.1. Overview
6.4.2. Protein Chips Market Revenue Forecasts and Analysis (US$ Mn)
6.5. LAB-ON-A-CHIP MARKET
6.5.1. Overview
6.5.2. Lab-On-A-Chip Market Revenue Forecasts and Analysis (US$ Mn)
6.6. OTHER ARRAYS MARKET
6.6.1. Overview
6.6.2. Other Arrays Market Revenue Forecasts and Analysis (US$ Mn)

7. BIOCHIP MARKET REVENUE AND FORECASTS TO 2027 - BY END USER
7.1. OVERVIEW
7.2. END USER MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. HOSPITALS & DIAGNOSTICS CENTERS MARKET
7.3.1. Overview
7.3.2. Hospitals & Diagnostics Centers Market Revenue Forecasts and Analysis (US$ Mn)
7.4. ACADEMIC & RESEARCH INSTITUTES MARKET
7.4.1. Overview
7.4.2. Academic & Research Institutes Market Revenue Forecasts and Analysis (US$ Mn)
7.5. BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES MARKET
7.5.1. Overview
7.5.2. Biotechnology & Pharmaceutical Companies Market Revenue Forecasts and Analysis (US$ Mn)

8. NORTH AMERICA BIOCHIP MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
8.1. NORTH AMERICA BIOCHIP MARKET OVERVIEW
8.2. NORTH AMERICA BIOCHIP MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
8.3. NORTH AMERICA BIOCHIP MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
8.4. NORTH AMERICA BIOCHIP MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
8.5. NORTH AMERICA BIOCHIP MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
8.6. US MARKET OVERVIEW
8.6.1. US Biochip Market Revenue Forecasts and Analysis - By Type (US$ Mn)
8.6.2. US Biochip Market Revenue Forecasts and Analysis - By End User (US$ Mn)
8.7. CANADA MARKET OVERVIEW
8.7.1. Canada Biochip Market Revenue Forecasts and Analysis - By Type (US$ Mn)
8.7.2. Canada Biochip Market Revenue Forecasts and Analysis - By End User (US$ Mn)
8.8. MEXICO MARKET OVERVIEW
8.8.1. Mexico Biochip Market Revenue Forecasts and Analysis - By Type (US$ Mn)
8.8.2. Mexico Biochip Market Revenue Forecasts and Analysis - By End User (US$ Mn)

9. EUROPE BIOCHIP MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
9.1. EUROPE BIOCHIP MARKET OVERVIEW
9.2. EUROPE BIOCHIP MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
9.3. EUROPE BIOCHIP MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
9.4. EUROPE BIOCHIP MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
9.5. EUROPE BIOCHIP MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY (US$ MN)
9.6. FRANCE MARKET OVERVIEW
9.6.1. France Biochip Market Revenue Forecasts and Analysis - By Type (US$ Mn)
9.6.2. France Biochip Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.7. GERMANY MARKET OVERVIEW
9.7.1. Germany Biochip Market Revenue Forecasts and Analysis - By Type (US$ Mn)
9.7.2. Germany Biochip Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.8. UK MARKET OVERVIEW
9.8.1. UK Biochip Market Revenue Forecasts and Analysis - By Type (US$ Mn)
9.8.2. UK Biochip Market Revenue Forecasts and Analysis - By End User (US$ Mn)

10. ASIA PACIFIC BIOCHIP MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
10.1. ASIA PACIFIC BIOCHIP MARKET OVERVIEW
10.2. ASIA PACIFIC BIOCHIP MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. ASIA PACIFIC BIOCHIP MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
10.4. ASIA PACIFIC BIOCHIP MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
10.5. ASIA PACIFIC BIOCHIP MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
10.6. CHINA MARKET OVERVIEW
10.6.1. China Biochip Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.6.2. China Biochip Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.7. INDIA MARKET OVERVIEW
10.7.1. India Biochip Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.7.2. India Biochip Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.8. JAPAN MARKET OVERVIEW
10.8.1. Japan Biochip Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.8.2. Japan Biochip Market Revenue Forecasts and Analysis - By End User (US$ Mn)

11. MIDDLE EAST AND AFRICA (MEA) BIOCHIP MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
11.1. MIDDLE EAST AND AFRICA (MEA) BIOCHIP MARKET OVERVIEW
11.2. MIDDLE EAST AND AFRICA (MEA) BIOCHIP MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. MIDDLE EAST AND AFRICA (MEA) BIOCHIP MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
11.4. MIDDLE EAST AND AFRICA (MEA) BIOCHIP MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
11.5. MIDDLE EAST AND AFRICA (MEA) BIOCHIP MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
11.6. SOUTH AFRICA MARKET OVERVIEW
11.6.1. South Africa Biochip Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.6.2. South Africa Biochip Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.7. SAUDI ARABIA MARKET OVERVIEW
11.7.1. Saudi Arabia Biochip Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.7.2. Saudi Arabia Biochip Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.8. UAE MARKET OVERVIEW
11.8.1. UAE Biochip Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.8.2. UAE Biochip Market Revenue Forecasts and Analysis - By End User (US$ Mn)

12. SOUTH AND CENTRAL AMERICA BIOCHIP MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
12.1. SOUTH AND CENTRAL AMERICA BIOCHIP MARKET OVERVIEW
12.2. SOUTH AND CENTRAL AMERICA BIOCHIP MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.3. SOUTH & CENTRAL AMERICA BIOCHIP MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
12.4. SOUTH AND CENTRAL AMERICA BIOCHIP MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
12.5. SOUTH AND CENTRAL AMERICA BIOCHIP MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
12.6. BRAZIL MARKET OVERVIEW
12.6.1. Brazil Biochip Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.6.2. Brazil Biochip Market Revenue Forecasts and Analysis - By End User (US$ Mn)

13. INDUSTRY LANDSCAPE
13.1. ORGANIC GROWTH STRATEGIES
13.1.1. New Product & Service Launches
13.1.2. Marketing & Promotional Activities
13.2. INORGANIC GROWTH STRATEGIES
13.2.1. Partnerships, Collaborations, and Joint Ventures
13.2.2. Mergers & Acquisitions

14. BIOCHIP MARKET, KEY COMPANY PROFILES
14.1. THERMO FISHER SCIENTIFIC INC
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Financial Overview
14.1.4. Product Portfolio
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. BIO-RAD LABORATORIES, INC.
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Financial Overview
14.2.4. Product Portfolio
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. ABBOTT
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Financial Overview
14.3.4. Product Portfolio
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. ILLUMINA, INC.
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Financial Overview
14.4.4. Product Portfolio
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. GENERAL ELECTRIC
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Financial Overview
14.5.4. Product Portfolio
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. AGILENT TECHNOLOGIES, INC.
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Financial Overview
14.6.4. Product Portfolio
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. PERKINELMER INC.
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Financial Overview
14.7.4. Product Portfolio
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. F. HOFFMANN-LA ROCHE LTD
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Financial Overview
14.8.4. Product Portfolio
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. FLUIDIGM CORPORATION
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Financial Overview
14.9.4. Product Portfolio
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. CEPHEID
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Financial Overview
14.10.4. Product Portfolio
14.10.5. SWOT Analysis
14.10.6. Key Developments

15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
15.3. RESEARCH METHODOLOGY
The List of Companies

1. Thermo Fisher Scientific Inc
2. Bio-Rad Laboratories, Inc.
3. Abbott
4. Illumina, Inc.
5. GENERAL ELECTRIC
6. Agilent Technologies, Inc.
7. PerkinElmer Inc.
8. F. Hoffmann-La Roche Ltd
9. Fluidigm Corporation
10. Cepheid